Miguel M Cabada1, A Clinton White. 1. Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA. micabada@utmb.edu
Abstract
PURPOSE OF REVIEW: This review focuses on the recent developments in the epidemiology, burden of disease, diagnostic tests, and treatment of fascioliasis. RECENT FINDINGS: Recent epidemiologic data suggest that either the endemic areas are expanding or disease is being recognized in areas where it was not previously observed. In addition, recent data highlight the effects of fascioliasis on childhood anemia and nutrition. Diagnosis remains problematic, but newer diagnostic tests including antibody, antigen, and DNA detection tests may facilitate earlier diagnosis. Recent studies suggest that point-of-care testing may soon be possible. Treatment with triclabendazole is effective, but resistance is emerging in livestock and may pose a threat for patients. SUMMARY: Fascioliasis continues to emerge as an important neglected disease, with new studies highlighting the under-recognized burden of disease. Further studies are needed on burden of disease, improved diagnosis, and alternative to triclabendazole treatment.
PURPOSE OF REVIEW: This review focuses on the recent developments in the epidemiology, burden of disease, diagnostic tests, and treatment of fascioliasis. RECENT FINDINGS: Recent epidemiologic data suggest that either the endemic areas are expanding or disease is being recognized in areas where it was not previously observed. In addition, recent data highlight the effects of fascioliasis on childhood anemia and nutrition. Diagnosis remains problematic, but newer diagnostic tests including antibody, antigen, and DNA detection tests may facilitate earlier diagnosis. Recent studies suggest that point-of-care testing may soon be possible. Treatment with triclabendazole is effective, but resistance is emerging in livestock and may pose a threat for patients. SUMMARY:Fascioliasis continues to emerge as an important neglected disease, with new studies highlighting the under-recognized burden of disease. Further studies are needed on burden of disease, improved diagnosis, and alternative to triclabendazole treatment.
Authors: Sun Hee Shin; Angel Hsu; Holly M Chastain; Lorna A Cruz; Eric S Elder; Sarah G H Sapp; Isabel McAuliffe; Ana M Espino; Sukwan Handali Journal: Am J Trop Med Hyg Date: 2016-08-22 Impact factor: 2.345
Authors: Miguel M Cabada; Mary R Goodrich; Brittany Graham; Pablo G Villanueva-Meyer; Martha Lopez; Eulogia Arque; A Clinton White Journal: Am J Trop Med Hyg Date: 2014-09-08 Impact factor: 2.345
Authors: Miguel M Cabada; Maria Luisa Morales; Camille M Webb; Logan Yang; Chelsey A Bravenec; Martha Lopez; Ruben Bascope; A Clinton White; Eduardo Gotuzzo Journal: Am J Trop Med Hyg Date: 2018-11 Impact factor: 2.345
Authors: Camille M Webb; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; A Clinton White; Miguel M Cabada Journal: PLoS Negl Trop Dis Date: 2021-06-21
Authors: Mohamad Ahmad Najib; Noor Jamil Noor Izani; Wan Abdul Wahab Wan Nor Amilah; Arizam Muhamad Faez; Zainuddin Shafizol Journal: Malays J Med Sci Date: 2020-02-27